DW Healthcare Partners, a Toronto-based private equity firm focused on healthcare, has closed its DW Healthcare Partners Small Cap LP, a fund focused on lower-middle-market healthcare investments. The fund raised $210 million in total capital commitments.

The fund, also known as the Founders Fund, will invest in companies that are $3 to 6 million Ebitda. The fund currently has two investments: TubeWriter and DermLite. The new fund brings DWHP’s total capital under management to $1.3 billion.

The Founders Fund has all the benefits of our firm-wide expertise, deep network of experienced operators and executives, and deal sourcing engine, which has over 66,000 healthcare companies in its database,” comments Andrew Carragher, co-founder and managing partner at DW Healthcare.

M2O Private Fund Advisors acted as DW Healthcare Partners’ placement agent in the U.S.; August Capital acted as placement agent in Canada; and Kirkland & Ellis LLP acted as legal counsel.